Impact of early surgery vs conventional treatment for infective endocarditis on mortality and embolic events: data from EASE trial Prospective RCT (2006-2011);

Slides:

Advertisements

Similar presentations

Aggressive Hyperglycemia Management. Significant hospital hyperglycemia requires close follow-up Previously diagnosed diabetes and elevated A1C Without.

Advertisements

Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)

AVR: Choice of Prosthesis Tirone E. David University of Toronto.

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.

Can we prevent stent restenosis after coronary stent implantation

Slide Source: Lipids Online Slide Library Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT): Design Cannon CP.

Prescribing Information is available at the end of this presentation NHS Surrey Lipid Guidelines Dr Adam Jacques Ashford & St.

TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.

ACC 2015 Michael J Reardon, MD, FACC On Behalf of the CoreValve US Investigators A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic.

SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators.

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter Aortic Valve Replacement Raghavendra Paknikar BS Jeffrey Friedman BS David.

HIV Early Treatment Project Groups 1 and 2 n Among HIV-infected participants in sub-Saharan Africa, does initiation of antiretroviral treatment (ART) at.

VBWG IDEAL: The Incremental Decrease in End Points Through Aggressive Lipid Lowering Study.

Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.

COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)

BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.

Efficacy of ampicillin plus ceftriaxone vs ampicillin plus gentamicin for Enterococcus faecalis infective endocarditis (EFIE) Multi-centre, observational,

Randomized, double-blind, multicenter, controlled trial.

Liver fibrosis regression after anti HCV therapy and the rate of death, liver-related death, liver- related complications, and hospital.

VBWG HPS. Lancet. 2003;361: Gæde P et al. N Engl J Med. 2003;348: Recent statin trials: Reduction in primary outcome in patients with diabetes.

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.

Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.

Inappropriate empirical antimicrobial Tx for coagulase-negative staphylococcal (CoNS) bacteraemia: impact on survival Single-centre retrospective cohort.

PET/CT vs TEE: diagnostic value for infective endocarditis (IE) Single-centre, prospective study ( ): N=45 adult pts (median age: 65 yr) with suspected.

New antibiotics against Gram-positive pathogens for acute bacterial skin and skin-structure infections (ABSSSIs) 3 international, multi-centre, double-blind,

Limbs International Medical Buflomedil Trial Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Alain Leizorovicz LIMB.

Surgical Outcomes of Infective Endocarditis among Intravenous Drug Abusers: Results from Two Large Academic Centers Joon Bum Kim 1,3, Julius I. Ejiofor.

Sakakibara Heart Institute Minoru Tabata, MD, MPH, Akihito Matsushita, MD, Toshihiro Fukui, MD, Shigefumi Matsuyama, MD, Tomoki Shimokawa, MD, Shuichiro.

ISKANDER AL-GITHMI, MD, FRCSC Consultant Cardiothoracic Surgeon Assistant Professor of Surgery King Abdulaziz University ISKANDER AL-GITHMI, MD, FRCSC.

Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.

Systematic review + meta-analysis: 69 (quasi-)randomised trials: N=7,863 pts with sepsis: any BL monoTx vs any combination of BL + AG: N (studies) : same.

Surgical outcome of native valve infective endocarditis in srinagarind hospital

Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis David H. Adams et al (U.S. CoreValve Clinical Investigators) Journal Club November.

Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction Benjamin M. Scirica, MD, MPH On behalf of the TRA 2°P-TIMI 50 Steering.

Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.

Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:

Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

Effect of losartan on aortic dilatation rate in adult patients with Marfan syndrome Maarten Groenink R Franken, AW den Hartog, T Radonic, V de Waard, AM.

COMET: Carvedilol Or Metoprolol European Trial Purpose To compare the effects of carvedilol (a β 1 -, β 2 - and α 1 -receptor blocker) and short-acting.

Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.

Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.

Azithromycin for the Secondary Prevention of Coronary Events J. Thomas Grayston, M.D., Richard A. Kronmal, Ph.D., Lisa A. Jackson, M.D., Alfred F. Parisi,

Caspofungin prophylaxis vs placebo, followed by preemptive Tx for invasive candidiasis (IC) in ICU pts: MSG-01 study Multi-centre, double-blind, phase.

Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:

Asymptomatic mitral regurgitation When should you operate? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester.

Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.

Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.

Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.

The STAR Study. Cardiovascular Disease Antihypertensives The STAR Study Stent Placement in Patients with Atherosclerotic Renal Artery Stenosis and Impaired.

Objective Bleeding events are grave and sometimes life threatening complications after prosthetic valve replacement, especially in hemodialysis patients.

Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.

Primary Mitral Regurgitation Degenerative Mitral Valve Disease

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from participants in 26 randomised trials Lancet 2010;

David J McCormack MFSTEd FRCSEd (CTh) Advanced Clinical Fellow

Early Surgery versus Conventional Treatment for Infective Endocarditis

MedStar Washington Hospital Center Cardiac Catheterization Conference

Brucella endocarditis fatal but underdiagnosed

Purpose Infective endocarditis (IE) which is an uncommon disease in pediatric patients can cause significant morbidity and mortality. IE is treated with.

AIM HIGH Niacin plus Statin to prevent vascular events

FATS- Familial Atherosclerosis Treatment Study

Nishith Patel Waikato Cardiothoracic Unit

Median total new lesion volume

PARTNER 2A Trial design: Intermediate-risk patients with aortic stenosis (STS PROM score 4-8%) were randomized to undergo either TAVR or SAVR, stratified.

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Enrollment and Outcomes

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Baseline Characteristics of the Study Participants

Kaplan-Meier plot for the prespecified primary endpoint (CARE-HF (A) and the secondary composite endpoint (all-cause mortality and new onset heart failure.

Presentation transcript:

Impact of early surgery vs conventional treatment for infective endocarditis on mortality and embolic events: data from EASE trial Prospective RCT ( ); median follow-up: 749 days N=76 pts with left-sided infective endocarditis, severe mitral or aortic valve disease and vegetations with diameter >10 mm Pts randomised to early surgery (within 48h after randomisation) (N=37) or conventional treatment * (based on current AHA guidelines) (N=39) Primary endpoint: composite of in-hospital death and embolic events occurring within 6 wk after randomisation No significant ≠ in baseline characteristics between both groups Kang DH et al. N Engl J Med 2012;366: of 2 * Surgery performed only in case of complications during medical treatment or in case of persistent symptoms after completion of antibiotic therapy

Primary endpoint (6 wk) Secondary endpoints (6 mo) Impact of early surgery vs conventional treatment for infective endocarditis on mortality and embolic events: data from EASE trial Compared with conventional treatment, early surgery significantly reduces the combined risk of death from any cause and embolic events, by decreasing the risk of systemic embolism Kang DH et al. N Engl J Med 2012;366: of 2

Impact of timing of cardiac surgery on mortality in pts with infective endocarditis and ischaemic stroke Multi-centre retrospective cohort study (data from International Collaboration on Endocarditis-Prospective Cohort Study; ) N=198 pts with infective endocarditis (IE) complicated by ischaemic cardiac stroke, who underwent post-stroke valve replacement surgery Treatment groups: –Early surgery: Within 1-7 days after cardiac stroke: N=58 (29.3%) –Late surgery: >7 days after cardiac stroke: N=140 (70.7%) Multivariable logistic regression Potential predictors of in-hospital mortality Barsic B et al. Clin Infect Dis 2013;56: of 2

Kaplan-Meier analysis/Cox regression analysis Potential predictors of 1-year mortality Impact of timing of cardiac surgery on mortality in pts with infective endocarditis and ischaemic stroke In pts with IE and stroke, delaying cardiac surgery may not significantly reduce in-hospital or 1-year mortality compared with early surgery Barsic B et al. Clin Infect Dis 2013;56: of 2